KRM Ayurveda opened higher at ₹266.00, compared with its previous close of ₹265.55. During today's session, the stock has traded between ₹263.00 and ₹272.95, with an average traded price of ₹267.55. It is currently showing an upward intraday trend.
return calculator
Time Period
An investment of ₹10,000 made 1 year ago in KRM Ayurveda is now worth
₹ 14,953.00
giving a profit of
₹ 4,953.00 (49.53%)
invest now
Note: Past profits do not guarantee future returns.
Analyst Overview
No analyst rating data available.
Markets Today
Today's Change
+4.65 (+1.75%)
Day High
₹272.95
Day Low
₹263.00
Day Open
₹266.00
Prev Close
₹265.55
Volume
1,64,000
Value Traded
₹4.39 Cr
1W Return
-0.63%
1M Return
-12.19%
3M Return
4.32%
6M Return
33.89%
1Y Return
49.53%
Fundamentals
Market Cap (₹ Cr.)
574
PE Ratio
-
PB Ratio
4.92
Dividend Yield
-
ROE
17.54%
ROCE
25.96%
Book Value (₹)
53.95
Face Value (₹)
10.00
EPS (TTM)
-
Industry PE
-
Beta
-
Debt to Equity
-
Investment Returns
1 Week
-0.63%
6 Week
-
1 Month
-12.19%
3 Month
4.32%
9 Month
49.53%
Financials
Yearly
All values in ₹ crores
No data available.
Share Holding Pattern
Promoter69.15%
FII3.86%
DII3.34%
Retails & Others14.87%
Updates
12Jul
KRM Ayurveda approves new Gurugram hospital to add 60-100 beds
KRM Ayurveda Ltd's board approved a new hospital in Gurugram to add 60-100 beds, funded by internal accruals, to address full capacity at its existing facility. The project, requiring an investment of ₹15 Lakhs, is set to commence operations in August 2026 at Sector-47, Gurugram.
3mo ago
17Jun
KRM Ayurveda to host investor meet on June 23 in Mumbai
KRM Ayurveda Ltd is conducting an investor meet on June 23, 2026, in Mumbai, organized by PhillipCapital. Managing Director Mr. Puneet Dhawan will lead the session, ensuring no unpublished price sensitive information is disclosed.
3mo ago
17Jun
KRM Ayurveda establishes MSS Hospital in New Delhi with 23 beds
KRM Ayurveda Ltd has established MSS Hospital in Pitampura, New Delhi, featuring 23 beds and spanning 5631 sq. ft. to provide IPD and OPD services. The move aligns with the company's goal to expand its healthcare footprint.
KRM Ayurveda filed its FY26 earnings call transcript with NSE on May 11, 2026, reporting revenue of ₹10,169.07 Lakh (+32.84% YoY), PAT of ₹2,012 Lakh (+79.42% YoY), and EBITDA margin of 30.60%. The company, now debt-free post-IPO, targets at least 50% revenue growth through 30 new super-specialty clinics, bed expansion from ~235 to ~500, a 25-bed luxury hospital in Delhi, and a 500-seat telemedicine center within 1–1.5 years.
